Phreesia, Inc. (NYSE:PHR) Receives $31.62 Consensus PT from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have earned an average rating of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $31.62.

A number of research analysts have issued reports on the stock. JMP Securities upped their price target on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research note on Thursday, March 21st. Robert W. Baird boosted their price target on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, March 18th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, March 15th. Truist Financial initiated coverage on shares of Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 price target for the company. Finally, Barclays started coverage on shares of Phreesia in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 price objective on the stock.

Insider Activity

In other news, General Counsel Allison C. Hoffman sold 5,549 shares of Phreesia stock in a transaction dated Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $125,518.38. Following the sale, the general counsel now owns 141,485 shares in the company, valued at $3,200,390.70. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, General Counsel Allison C. Hoffman sold 5,549 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $125,518.38. Following the completion of the transaction, the general counsel now directly owns 141,485 shares of the company’s stock, valued at approximately $3,200,390.70. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Janet Gunzburg sold 2,817 shares of the company’s stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $23.27, for a total value of $65,551.59. Following the completion of the sale, the insider now owns 40,609 shares of the company’s stock, valued at $944,971.43. The disclosure for this sale can be found here. Insiders have sold 81,808 shares of company stock worth $1,884,749 in the last quarter. Corporate insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of PHR. State of Wyoming lifted its position in shares of Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after purchasing an additional 493 shares in the last quarter. American International Group Inc. grew its position in shares of Phreesia by 2.3% during the fourth quarter. American International Group Inc. now owns 26,342 shares of the company’s stock worth $610,000 after buying an additional 591 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Phreesia by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 20,545 shares of the company’s stock worth $637,000 after buying an additional 710 shares during the period. Capital Impact Advisors LLC raised its holdings in Phreesia by 4.2% in the fourth quarter. Capital Impact Advisors LLC now owns 21,262 shares of the company’s stock valued at $688,000 after acquiring an additional 851 shares in the last quarter. Finally, Captrust Financial Advisors lifted its stake in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after acquiring an additional 866 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of PHR opened at $22.62 on Tuesday. The company has a 50 day moving average of $24.40 and a two-hundred day moving average of $21.26. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -8.98 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia has a twelve month low of $12.05 and a twelve month high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. During the same quarter last year, the firm earned ($0.72) EPS. The business’s quarterly revenue was up 24.0% on a year-over-year basis. As a group, analysts predict that Phreesia will post -1.48 earnings per share for the current fiscal year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.